SignatureFD’s Organogenesis Holdings ORGO Stock Holding History

SignatureFD’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-182	Closed	-$943	–	3561
2025 Q4	$943	Hold	182	–	–	﹤0.01%	3129
2025 Q3	$768	Hold	182	–	–	﹤0.01%	3129
2025 Q2	$666	Sell	182 -235	-56%	-$876	﹤0.01%	3070
2025 Q1	$1.8K	Buy	417 +235	+129%	+$949	﹤0.01%	2902
2024 Q4	$582	Hold	182	–	–	﹤0.01%	3123
2024 Q3	$521	Sell	182 -19	-9%	-$53	﹤0.01%	3094
2024 Q2	$563	Buy	+201	New	+$539	﹤0.01%	2974
2024 Q1	–	Sell	-700	Closed	-$2.86K	–	3237
2023 Q4	$2.86K	Buy	+700	New	+$1.96K	﹤0.01%	2669
2023 Q3	–	Sell	-713	Closed	-$2.37K	–	3272
2023 Q2	$2.37K	Sell	713 -647	-48%	-$1.91K	﹤0.01%	2755
2023 Q1	$2.9K	Buy	1,360 +151	+12%	+$373	﹤0.01%	2698
2022 Q4	$3.25K	Buy	1,209 +536	+80%	+$1.56K	﹤0.01%	2636
2022 Q3	$2K	Buy	+673	New	+$3.04K	﹤0.01%	2821
2021 Q4	–	Sell	-200	Closed	-$3K	–	3220
2021 Q3	$3K	Buy	+200	New	+$3.11K	﹤0.01%	2539
2020 Q2	–	Sell	-150	Closed	–	–	2616
2020 Q1	$0	Buy	+150	New	+$642	﹤0.01%	2408

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SignatureFD's ORGO Position: Q1 2026 in Review

SignatureFD sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 182 shares — an estimated $943 sold.

SignatureFD first reported a position in ORGO in Q1 2020 and held it in 14 quarters. The position peaked at $3.25K in Q4 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

SignatureFD reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
SignatureFD sold 182 Organogenesis Holdings shares in Q1 2026, an estimated $943.
SignatureFD first reported a position in Organogenesis Holdings in Q1 2020 and held it in 14 quarters.
SignatureFD's Organogenesis Holdings position peaked at $3.25K in Q4 2022.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.